Don't want to miss the best from Business Standard?
Jeena Sikho Lifecare has received approval for conducting a clinical trial on the following products:
1. Anti-Diabetes Efficacy of SDM02 Tablets - Pre-clinical study conducted at MIET, Meerut, on streptozotocin-induced diabetic rats. The tablets were found effective with no mortality or adverse effects at the tested dose.
2. Shuddhi XS Syrup - Clinical trial on 60 subjects with constipation conducted at CCFT Laboratories, Meerut. 92% reported relief in constipation and abdominal pain, with no adverse events.
3. Petshuddhi Churna - Retrospective clinical study on 100 patient records conducted at Hospital & Institute of Integrated Medical Sciences, Meerut. Significant improvement observed in bowel movement, stool consistency, and abdominal discomfort. No adverse events reported.
4. Shuddhi Dr. B P Care Tablets - Clinical trial on 60 hypertensive patients conducted at CCFT Laboratories, Meerut. Significant reduction in systolic and diastolic blood pressure and heart rate was observed within 2-3 hours and sustained for 6 hours. No adverse events reported.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app